SciClone Pharmaceuticals (Holdings) Limited

03 MAR 2021

SciClone Pharmaceuticals (Holdings) Limited (the company) is a biopharmaceutical company with an integrated platform for product development and commercialization. It strategically focuses on some of the largest and fast-growing therapeutic areas with significant unmet medical needs in China, primarily including oncology and severe infection. Leveraging its capabilities in product development and commercialization, the Company strives to develop and commercialize a portfolio of high-quality marketed products, and pipeline drugs in the focused therapeutic areas.

賽生藥業控股有限公司* (「公司」)是一家擁有產品開發和商業化集成平台的生物製藥公司,戰略上專注於中國一些最大且發展迅速的醫療需求未得到滿足的治療領域,包括腫瘤科及重症感染。憑藉賽生藥業的產品開發及商業化實力,公司力圖在重點治療領域開發優質的上市產品及在研產品的組合並對其進行商業化。

* For identification purpose only / 僅供識別